Janus Kinase Inhibitors [MoA] - N0000190857

Name: Table of NDC products with janus kinase inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000190857
Pharmacologic Name	Janus Kinase Inhibitors
Pharmacologic Uses	Janus kinase (JAK) inhibitor kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Janus Kinase Inhibitors

The table contains 30 products whose active ingredient are classified under the same pharmacologic class Janus Kinase Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0002-4182	Olumiant	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0002-4479	Olumiant	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0002-4732	Olumiant	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0002-6885	Baricitinib	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0069-0235	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0335	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0435	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0501	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated, Extended Release	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0502	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated, Extended Release	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1001	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1002	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1029	Xeljanz	Non-Proprietary Name: Tofacitinib	Solution	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0074-1043	Rinvoq	Non-Proprietary Name: Upadacitinib	Tablet, Extended Release	Oral	Abbvie Inc.	ACTIVE
0074-2306	Rinvoq	Non-Proprietary Name: Upadacitinib	Tablet, Extended Release	Oral	Abbvie Inc.	ACTIVE
0074-2310	Rinvoq	Non-Proprietary Name: Upadacitinib	Tablet, Extended Release	Oral	Abbvie Inc.	ACTIVE
0074-2320	Rinvoq	Non-Proprietary Name: Upadacitinib	Solution	Oral	Abbvie Inc.	ACTIVE
50881-005	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-007	Opzelura	Non-Proprietary Name: Ruxolitinib	Cream	Topical	Incyte Corporation	ACTIVE
50881-010	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-015	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-020	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-025	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
63539-012	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-016	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-236	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-336	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-436	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-501	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Extended Release	Oral	U.s. Pharmaceuticals	ACTIVE
63539-502	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Extended Release	Oral	U.s. Pharmaceuticals	ACTIVE
72482-100	Vonjo	Non-Proprietary Name: Pacritinib	Capsule	Oral	Cti Biopharma Corp.	ACTIVE